{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:47:23Z","timestamp":1769734043527,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Health and Medical Care Executive Board of the V\u00e4stra G\u00f6taland"},{"name":"Rune and Ulla Aml\u00f6vs foundation for Rheumatology Research"},{"DOI":"10.13039\/501100008106","name":"G\u00f6teborg\u2019s Association Against Rheumatism","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008106","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Medical Society of G\u00f6teborg"},{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1354-7","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T13:32:18Z","timestamp":1481549538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-0144","authenticated-orcid":false,"given":"Karin","family":"Bengtsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart T. H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbro","family":"Rydberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Kvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Torstenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Dehlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Hilme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lindh\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna Maria","family":"Wallerstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Forsblad-d\u2019Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"issue":"3","key":"1354_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005;4(3):130\u20136.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/annrheumdis-2013-204577","volume":"73","author":"JL Nam","year":"2014","unstructured":"Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2014;73(3):516\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1354_CR3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.autrev.2014.08.026","volume":"13","author":"EG Favalli","year":"2014","unstructured":"Favalli EG, Biggioggero M, Meroni PL. Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an \u201canchor\u201d drug? Autoimmun Rev. 2014;13(11):1102\u20138.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1354_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/ard.2007.070714","volume":"67","author":"MK Soderlin","year":"2008","unstructured":"Soderlin MK, Geborek P. Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden. Ann Rheum Dis. 2008;67(1):37\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1354_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/annrheumdis-2013-204021","volume":"74","author":"J Listing","year":"2015","unstructured":"Listing J, Kekow J, Manger B, Burmester GR, Pattloch D, Zink A, et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFalpha inhibitors and rituximab. Ann Rheum Dis. 2015;74(2):415\u201321.","journal-title":"Ann Rheum Dis"},{"key":"1354_CR6","doi-asserted-by":"crossref","first-page":"iii30","DOI":"10.1136\/ard.2008.098038","volume":"67 Suppl 3","author":"SE Gabriel","year":"2008","unstructured":"Gabriel SE, Suppl 3. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. 2008;67 Suppl 3:iii30\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1354_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","volume":"52","author":"J Listing","year":"2013","unstructured":"Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology (Oxford). 2013;52(1):53\u201361.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1354_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/kes189","volume":"52","author":"C Turesson","year":"2013","unstructured":"Turesson C, Matteson EL. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford). 2013;52(1):5\u201314.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1354_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.berh.2011.10.009","volume":"25","author":"NJ Gullick","year":"2011","unstructured":"Gullick NJ, Scott DL. Co-morbidities in established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2011;25(4):469\u201383.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"1354_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DP Symmons","year":"2011","unstructured":"Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7(7):399\u2013408.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1354_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/annrheumdis-2012-201387","volume":"72","author":"M Holmqvist","year":"2013","unstructured":"Holmqvist M, Gransmark E, Mantel A, Alfredsson L, Jacobsson LT, Wallberg-Jonsson S, et al. Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis. Ann Rheum Dis. 2013;72(4):541\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"1354_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/2012.jama.11741","volume":"308","author":"ME Holmqvist","year":"2012","unstructured":"Holmqvist ME, Neovius M, Eriksson J, Mantel A, Wallberg-Jonsson S, Jacobsson LT, et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA. 2012;308(13):1350\u20136.","journal-title":"JAMA"},{"issue":"9","key":"1354_CR13","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303\u20137.","journal-title":"Circulation"},{"issue":"8","key":"1354_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/ard.2003.018101","volume":"63","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis. 2004;63(8):952\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1354_CR15","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson Jr DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33(11):2167\u201372.","journal-title":"J Rheumatol"},{"issue":"4","key":"1354_CR16","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar3442","volume":"13","author":"L Innala","year":"2011","unstructured":"Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther. 2011;13(4):R131.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"1354_CR17","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.24836","volume":"61","author":"MJ Peters","year":"2009","unstructured":"Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? a prospective study. Arthritis Rheum. 2009;61(11):1571\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1354_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69(2):325\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1354_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ejim.2012.06.016","volume":"23","author":"H John","year":"2012","unstructured":"John H, Kitas G. Inflammatory arthritis as a novel risk factor for cardiovascular disease. Eur J Intern Med. 2012;23(7):575\u20139.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1354_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.autrev.2005.12.006","volume":"5","author":"A Abou-Raya","year":"2006","unstructured":"Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev. 2006;5(5):331\u20137.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1354_CR21","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1186\/ar4584","volume":"16","author":"L Ljung","year":"2014","unstructured":"Ljung L, Askling J, Rantapaa-Dahlqvist S, Jacobsson L. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study. Arthritis Res Ther. 2014;16(3):R127.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1354_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/ard.2010.129916","volume":"70","author":"JD Greenberg","year":"2011","unstructured":"Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(4):576\u201382.","journal-title":"Ann Rheum Dis"},{"key":"1354_CR23","unstructured":"Statistics Sweden. http:\/\/www.statistikdatabasen.scb.se . Accessed 4 Feb 2015."},{"issue":"10","key":"1354_CR24","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1136\/ard.2011.151902","volume":"70","author":"K Raza","year":"2011","unstructured":"Raza K, Stack R, Kumar K, Filer A, Detert J, Bastian H, et al. Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis. 2011;70(10):1822\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1354_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/03009742.2014.927918","volume":"44","author":"H Wadstrom","year":"2015","unstructured":"Wadstrom H, Eriksson JK, Neovius M, Askling J. How good is the coverage and how accurate are exposure data in the swedish biologics register (ARTIS)? Scand J Rheumatol. 2015;44(1):22\u20138.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1354_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML. van \u2019t Hof MA, kuper HH, van leeuwen MA, van de putte LB, van riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1354_CR27","first-page":"167","volume":"30","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF. The Stanford health assessment questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30(1):167\u201378.","journal-title":"J Rheumatol"},{"issue":"8","key":"1354_CR28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/kep129","volume":"48","author":"BJ Radovits","year":"2009","unstructured":"Radovits BJ, Fransen J, Eijsbouts A, van Riel PL, Laan RF. Missed opportunities in the treatment of elderly patients with rheumatoid arthritis. Rheumatology (Oxford). 2009;48(8):906\u201310.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1354_CR29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/ard.2005.051144","volume":"65","author":"Z Tutuncu","year":"2006","unstructured":"Tutuncu Z, Reed G, Kremer J, Kavanaugh A. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis. 2006;65(9):1226\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1354_CR30","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/ar4540","volume":"16","author":"L Innala","year":"2014","unstructured":"Innala L, Berglin E, Moller B, Ljung L, Smedby T, Sodergren A, et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis Res Ther. 2014;16(2):R94.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1354_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/ard.2010.133371","volume":"70","author":"M Neovius","year":"2011","unstructured":"Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis. 2011;70(4):624\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1354_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10067-014-2750-8","volume":"34","author":"A Nakajima","year":"2015","unstructured":"Nakajima A, Inoue E, Shimizu Y, Kobayashi A, Shidara K, Sugimoto N, et al. Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis. Clin Rheumatol. 2015;34(3):441\u20139.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"1354_CR33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/ard.2006.062760","volume":"66","author":"J Askling","year":"2007","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al. Time-dependent increase in risk of hospitalisation with infection among swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007;66(10):1339\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1354_CR34","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2294\u2013300.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1354_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1354_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/ard.2005.043158","volume":"65","author":"K Hyrich","year":"2006","unstructured":"Hyrich K, Symmons D, Watson K, Silman A. Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register. Ann Rheum Dis. 2006;65(7):895\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1354_CR37","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar2383","volume":"10","author":"A Naranjo","year":"2008","unstructured":"Naranjo A, Sokka T, Descalzo MA, Calvo-Alen J, Horslev-Petersen K, Luukkainen RK, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008;10(2):R30.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1354_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kes262","volume":"52","author":"S Norton","year":"2013","unstructured":"Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford). 2013;52(1):99\u2013110.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1354_CR39","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1002\/art.27660","volume":"62","author":"M Lunt","year":"2010","unstructured":"Lunt M, Watson KD, Dixon WG, Symmons DP, Hyrich KL. No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British society for rheumatology biologics register. Arthritis Rheum. 2010;62(11):3145\u201353.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1354_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/keq127","volume":"49","author":"M Englund","year":"2010","unstructured":"Englund M, Joud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology (Oxford). 2010;49(8):1563\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1354_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-016-1354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:56:38Z","timestamp":1749822998000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1354-7","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"499"}}